Artwork

Content provided by Dr. Jeremy Koenig. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeremy Koenig or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 47: Genomics, Rare Diseases, and the Power of Collaboration with Dr. Chris McMaster

1:06:12
 
Share
 

Manage episode 468546977 series 3579438
Content provided by Dr. Jeremy Koenig. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeremy Koenig or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Dr. Chris McMaster, a leading geneticist and former Dean of Medicine at Dalhousie University, joins The DNA of Things to explore the transformative potential of gene therapy in treating rare diseases. As the scientific director of the Canadian Institute of Health Research’s Institute of Genetics, he sheds light on how genetic and genomic medicine is shifting from treating symptoms to curing diseases at the DNA level. Dr. McMaster shares insights into the ethical dilemmas of genetic data, the power of collaboration in scientific innovation, and the future of newborn genome sequencing. With a career spanning groundbreaking contributions to pharmacogenetics and orphan disease treatments, he discusses his latest venture, Allogene, and how his work in muscular dystrophies and infectious diseases is paving the way for a healthier future. Tune in for a compelling conversation about the evolving landscape of genetic research and its real-world impact on medicine.

Episode Highlights:

  • Gene therapy is revolutionizing medicine
  • Genome sequencing is now faster and more affordable
  • Scientific collaboration accelerates innovation
  • Newborn genome sequencing will transform early diagnosis
  • Genetic data privacy and ethics are crucial concerns
  • AI and bioinformatics are reshaping medical diagnostics
  • Small biotech companies are driving rare disease treatments
  • Medical research must prioritize patient impact over publications

Connect with Dr. Chris

LINKS:
https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

Here's the link for this week's episode: https://drjeremykoenig.substack.com/.

  continue reading

61 episodes

Artwork
iconShare
 
Manage episode 468546977 series 3579438
Content provided by Dr. Jeremy Koenig. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Jeremy Koenig or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Dr. Chris McMaster, a leading geneticist and former Dean of Medicine at Dalhousie University, joins The DNA of Things to explore the transformative potential of gene therapy in treating rare diseases. As the scientific director of the Canadian Institute of Health Research’s Institute of Genetics, he sheds light on how genetic and genomic medicine is shifting from treating symptoms to curing diseases at the DNA level. Dr. McMaster shares insights into the ethical dilemmas of genetic data, the power of collaboration in scientific innovation, and the future of newborn genome sequencing. With a career spanning groundbreaking contributions to pharmacogenetics and orphan disease treatments, he discusses his latest venture, Allogene, and how his work in muscular dystrophies and infectious diseases is paving the way for a healthier future. Tune in for a compelling conversation about the evolving landscape of genetic research and its real-world impact on medicine.

Episode Highlights:

  • Gene therapy is revolutionizing medicine
  • Genome sequencing is now faster and more affordable
  • Scientific collaboration accelerates innovation
  • Newborn genome sequencing will transform early diagnosis
  • Genetic data privacy and ethics are crucial concerns
  • AI and bioinformatics are reshaping medical diagnostics
  • Small biotech companies are driving rare disease treatments
  • Medical research must prioritize patient impact over publications

Connect with Dr. Chris

LINKS:
https://www.drjeremykoenig.com/
https://www.instagram.com/drjeremykoenig/
https://www.youtube.com/@drjeremykoenig

Here's the link for this week's episode: https://drjeremykoenig.substack.com/.

  continue reading

61 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play